Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

New dosage strengths of Coumadin available

Feb. 18, 1997

Ibustrin for diabetic vascular complications

Feb. 18, 1997

Ortho synthesizes inhibitors of serine proteases

Feb. 18, 1997

COR Therapeutics discloses factor Xa inhibitors

Feb. 18, 1997

Comparative study of second-generation t-PA inhibitor and alteplase

Feb. 17, 1997

Anti-factor Xa compounds disclosed by RPR

Feb. 14, 1997

ZymoGenetics/Novo Nordisk isolate anticlotting agent

Feb. 14, 1997

FDA approves product for hemophilia

Feb. 13, 1997

Roberts receives approvable letter from FDA for Agrylin

Feb. 12, 1997

Potent gpIIb/IIIa antagonist synthesized using combinatorial techniques

Feb. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...